This interactive face-to-face program equips primary care practitioners with the knowledge, skills, and confidence to test, diagnose, assess, manage, and treat hepatitis B and hepatitis C. Participants will explore evidence-based approaches to clinical management, treatment pathways, and ongoing support for individuals and families, with the goal of improving health outcomes and reducing the burden of viral hepatitis in the community.

Scholarship Applications Now Open!

ASHM is pleased to offer a limited number of scholarships to support attendance at this event. Scholarships may cover travel and accommodation costs, flights, meals, and taxi reimbursement.
Applications are open to individuals who are part of the event’s target audience and will be assessed based on submission time, financial need, and other extenuating circumstances.
While we aim to support as many people as possible, we are only able to provide scholarships to a small number of applicants who require assistance to attend. Successful applicants will be notified by June, 13 2026.
To apply for a scholarship for this event, please register to this event and respond to this brief survey here.

• Date: Saturday, 4 July 2026
• Time: 9:00am – 1:00pm (AWST)
• Venue: Aloft Hotel | The Springs, 27 Rowe Ave, Rivervale WA 6103
  • View location on Google Maps

Learning Outcomes:

On completion of this course and its components, participants will be able to:

• Discuss the impact of stigma and discrimination on people living with, or at risk of, hepatitis C
• Identify indications for testing and how to diagnose hepatitis C infection
• Describe key elements of pre-treatment assessment for hepatitis C
• Explain hepatitis C treatment and post-treatment monitoring
• Identify priority populations for hepatitis B testing in Australia 
• Interpret hepatitis B serology results
• Describe the role of primary care in the testing, diagnosis and management of patients with hepatitis B in the community

Course Components:

• (Optional) Completion of both Learning modules can add an additional 2 CPD hours: Online Learning Modules: Clinical Foundations of Hepatitis B and Online Learning Modules: Clinical Foundation of Hepatitis C
• 90-minute hepatitis B session
• 90-minute hepatitis C session
• Post-course survey

Recommended Resources:

• ASHM’s Decision-making in Hepatitis B tool
• ASHM’s Decision-making in Hepatitis C tool
• B Positive: Hepatitis B Guide for Primary Care
• Managing Hepatitis C in Australia
• New national strategies set path to eliminate hepatitis B and C | Australian Centre for Disease Control

CPD & Endorsement:

• RACGP: This course has been approved as a CPD activity by RACGP for the 2026-2028 triennium. Educational Activities: 3. Completion of this course will also earn participants 1 hepatitis B s100 Prescriber Point. RACGP Activity IDs: 1570757, 1573355
• ACCRM: This course has been approved as a CPD activity by ACRRM for the 2026-2028 triennium. Educational Activities: 3. Completion of this course will also earn participants 1 hepatitis B s100 Prescriber Point. ACRRM Activity IDs: 41413, 41447
• A statement of attendance will be provided for full attendees.

Funding:

This activity is funded by the Western Australian Department of Health.

Target Audience:

General practitioners, nurse practitioners, and other health professionals practicing in a primary care setting, including those intending to prescribe s85 direct acting antiviral medication for the treatment of hepatitis C, and those working towards obtaining or maintaining hepatitis B s100 prescriber accreditation.